
|Articles|September 23, 2015
Shaji Kumar on Treatment-Related Adverse Events From Monoclonal Antibodies
Author(s)Shaji Kumar
Shaji Kumar, professor of medicine, Division of Hematology, Mayo Clinic, discusses common treatment-related adverse events from monoclonal antibodies in patients with multiple myeloma.
Advertisement
Shaji Kumar, professor of medicine, Division of Hematology, Mayo Clinic, discusses common treatment-related adverse events from monoclonal antibodies in patients with multiple myeloma.
The main adverse event that is seen is infusion reactions, Kumar says. These reactions are easily managed and, even so, usually go away on their own.
Advertisement
Related Content
Advertisement
Advertisement
Trending on CURE
1
Imfinzi With Chemo Produces Inconclusive Outcomes in Phase 3 Mesothelioma Study
2
Imfinzi Combo Improves Progression Free Survival in Ovarian Cancer
3
Trodelvy in Metastatic Triple-Negative Breast Cancer Supported by Phase 3 Trial
4
Trodelvy Improves Survival in EGFR-Mutated Non-Small Cell Lung Cancer
5